INVEGA SUSTENNA® is approved for the treatment of schizoaffective disorder
INJECTION CENTER LOCATOR
This mapping tool shows possible pharmacies or other locations that are part of the JANSSEN CONNECT® Network and are able to administer a Janssen long-acting injectable atypical antipsychotic. Locations displayed are for informational purposes only.
Find an Injection Center
In order to enroll a patient, a healthcare professional needs to submit
a completed Patient Enrollment Form to Janssen CarePath.
To enroll a patient in Janssen CarePath, call 877-524-3579, Monday–Friday, 8 AM–8 PM ET
There are no results found.
Inclusion of Alternate Site of Care (“ASOC”) in this Janssen CarePath program does not represent an endorsement, referral or recommendation from JPI. ASOC is solely responsible and liable for the quality of patient care provided by the ASOC. In no event shall JPI or its affiliates, employees or agents incur any liability or responsibility for such patient care.
Information and assistance (eg, information regarding access and reimbursement, the inpatient/outpatient appointment gap, medication shipment, additional ASOCs, and follow-through of healthcare professional–directed treatment plan) are provided by third-party Program Administrators for Janssen CarePath (“Program Administrator”), under contract with JPI.
A Patient Enrollment Form, with sections completed for requested information regarding assistance, must be submitted to Program Administrator by the healthcare professional (“HCP”) in order to activate any Janssen CarePath assistance. No other forms for request for access to Janssen CarePath will be accepted. Assistance cannot be directly requested by the patient. Janssen CarePath is not available to patients participating in the Patient Assistance Program offered by Johnson & Johnson Patient Assistance Foundation. The availability of information and assistance may vary based on geography.
Program Administrator provides information to HCPs regarding whether the treatment is covered by the applicable third-party payer, based on the payer’s coverage guidelines and the patient information provided by the HCP. This information and assistance are made available as a convenience to patients, and there is no requirement that patients or HCPs use any JPI or other Johnson & Johnson product in exchange for this information or assistance.
JPI assumes no responsibility for and does not guarantee the quality, scope, or availability of the information and assistance provided (eg, information regarding access and reimbursement, the inpatient/outpatient appointment gap, medication shipment, additional ASOC, and follow-through of HCP-directed treatment plan). Program Administrator, not JPI, is responsible for the information and assistance it provides under this program. Each HCP and patient is responsible for verifying or confirming any information provided by Program Administrator or JPI. All claims and other submissions to payers should be in compliance with all applicable requirements.
Analytics (eg, data points or statistics about the program), if provided, are as of the date noted and may not be representative of future analytics or your patients or practice. Please consider appropriate use of Janssen CarePath information and assistance in light of your practice and individual patients’ clinical needs and applicable payer requirements.